Oryza
Latest round
- Series C
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 4
About Oryza
, trading as Oryza, operates as a pharmaceutical company dedicated to researching and developing new and improved drugs and generic drugs. The company's research and development facility is in Coral Springs, Florida, USA, and it has sub-branch offices in Beijing and Hong Kong. In February 2023, Oryza cooperated with the American company Reflexiv+. The company mainly produces new drugs and generic drugs with sustained and controlled-release properties. There are five drug forms which are solid, liquid, semi-solid, patch, and nanospray. The products can be used in curing diabetes, digestive system diseases, cardiovascular and cerebrovascular diseases, malignant tumors, and other symptoms. Oryza’s release technology can be used in natural plants, herbal traditional Chinese medicine, biopharmaceutical ingredients, and other fields. The products are also exported to the US. The company's revenue is generated by providing generic drugs and improved new drugs.
Who invested in Oryza
4 investors across 3 rounds
See all investors in Oryza
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oryza
Who invested in Oryza?
Oryza has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oryza raised?
Oryza has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Oryza last raise money?
Oryza's most recent round on record is a Series C, in Dec 2025.
What does Oryza do?
, trading as Oryza, operates as a pharmaceutical company dedicated to researching and developing new and improved drugs and generic drugs.
Where is Oryza headquartered?
Oryza is headquartered in Shenzhen, China.
Which VCs invest in companies like Oryza?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Oryza's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Oryza? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.